Self-Management of oral Anticoagulation in nonvalvular Atrial Fibrillation (SMAAF study)

Zeitschrift fur Kardiologie

Volumn 94, Issue 3, 2005, Pages 182-186

  Voller H ^a   Glatz, J ^a   Taborski, U ^c   Bernardo, A ^d   Dovifat, C ^a   Heidinger, K ^b  

^a Klinik am See   (Germany)

^b Inst F Klin Immunol T   (Germany)

^c Deutsche Gesell fur Humanplasma   (Germany)

^d Klinik Gais   (Switzerland)

Author keywords

Anticoagulation; Atrial fibrillation; INR self management

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENERAL PRACTITIONER; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; QUALITY CONTROL; SIDE EFFECT; THROMBOEMBOLISM;

ADMINISTRATION, ORAL; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; FAMILY PRACTICE; FEMALE; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; SELF CARE; THROMBOEMBOLISM;

EID: 15444365343     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-005-0199-0     Document Type: Article

References (30)

1. Atrial fibrillation investigators (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation; analysis of pooled data from five randomized controlled trials. Arch Intern Med 154:1449-1457
2. Butchart EG, Payne N, Li H-H, Buchan K, Mandana K, Grunkemeier GL (2002) Better anticoagulation control improves survival after valve replacement. J Thorac Cardiovasc Surg 123:715-723
3. Carlsson J, Miketic S, Flicker E, Erdogan A, Haun S, Cuneo A, Tebbe U (2002) Neurologische Ereignisse bei Patienten mit Vorhofflimmern: Outcome und Präventionspraxis. Z Kardiol 89:1090-1097
4. Copland M, Walker ID, Tait RC (2001) Oral Anticoagulation and Hemorrhagic Complications in an Elderly Population With Atrial Fibrillation. Arch of Int Med 161:2125-2128
5. EAFT study group (1993) Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet 342: 1255-1262
6. European Atrial Fibrillation Study Group (1995) Optimal oral anticoagulation therapy with nonrheumatic atrial fibrillation and recent cerebral ischemia. New Engl J Med 333:5-10
7. Fang MC, Stafford RS, Ruskin JN, Singer DE (2004) National Trends in Antiarrhythmic and Antithrombotic Medication Use in Atrial Fibrillation. Arch Intern Med 164:55-60
8. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370-2375
9. Heidinger KS, Bernardo A, Taborski U, Mueller-Berghaus G (2000) Clinical outcome of self-management of oral anticoagulation in patients with atrial fibrillation or deep vein thrombosis. Thromb Res 98:287-293
10. Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE (2003) Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation. N Engl J Med 349:1019-1026
11. Hylek EM, Skates SJ, Sheehan MA, Singer DE (1996) An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 335:540-546
12. Israel CW, Gronefeld G, Ehrlich JR, Li YG, Hohnloser SH (2004) Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol 43:47-52
13. Kannel WB, Abbort RD, Savage DD, McNamara PM (1983) Coronary heart disease and atrial fibrillation: The Framingham study. Am Heart J 106:389-396
14. Körtke H, Körfer R (2001) International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Ann Thorac Surg 72:44-48
15. Man-Son-Hing M, Nichol G, Lau A, Laupacis A (1999) Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med 159: 677-685
16. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berrettini M, Musolesi S, on behalf of the Italian Study on Complications of Oral Anticoagulant Therapy (1996) Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet 348:423-428
17. Rossol-Haseroth K, Vogel CU, Reinecke F, Burkhardt H, Heun-Letsch Ch, Wieth B, Peiter A, Heinrich U, Jorg I, Voller H, Kemkes-Matthes B, Nordt TK, Diener HC, Gehrlein M, Gladisch R, Wehling M, Harenberg J (2002) Empfehlungen zur Thromboembolieprophylaxe bei internistischen Patienten im Alter. Internist 43:1134-1147
18. Saxena R, Lewis S, Berge E, Sandercock PAG, Koudstaal PJ; for the International Stroke Trial Collaborative Group (2001) Risk of Early Death and Recurrent Stroke and Effect of Heparin in 3169 Patients With Acute Ischemic Stroke and Atrial Fibrillation in the International Stroke Trial. Stroke 32:2333-2337
19. Scott PA, Pancioli AM, Davis LA, Frederiksen SM, Eckman J (2002) Prevalence of atrial fibrillation and antithrombotic prophylaxis in emergency department patients. Stroke 33:2664-2669
20. Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA (1998) Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet 352:1167-1171
21. Van der Meer FJM, Rosendaal FR, Vandenbroucke JP, Briet E (1996) Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants. Thromb Haemost 76:12-16
22. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJM, Tijssen JGP, Crijns HJGM for the Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347:1834-1840
23. Van Swieten JC, Kondstaal PJ, Visser MC, Schonten HJA, van Gijn J (1988) Interobserver aggreement in stroke patients. Stroke 19:604-607
24. Völler H, Glatz J, Taborski U, Bernardo A, Dovifat C, Burkard G, Heidinger K (2000) für die SMAAF-Studiengruppe (2000) Hintergrund und Prüfplan der Studie zum Selbstmanagement der Antikoagulation bei Patienten mit nichtvalvulärem Vorhofflimmern (SMAAF-Studie). Z Kardiol 89: 284-288
25. Völler H, Dovifat C, Glatz J (2001) Home management of anticoagulation. Eur Heart J Suppl (Suppl Q): Q44-Q49
26. Völler H, Dovifat C, Glatz J, Krüger-Streller B, Tamkus A, Wegscheider K (2003) Lower INR Variability through Self management of Oral Anticoagulation Annals of Hematology (Suppl 1)82:306
27. Watzke HH, Forberg E, Svolba G, Jimenez-Boj E, Krinninger B (2000) A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation. Thromb Haemost 83:661-665
28. Whittle J, Wickenheiser L, Venditti LN (1997) Is warfarin underused in the treatment of elderly persons with atrial fibrillation? Arch Intern Med 157:441-445
29. Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 22:983-988
30. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD, Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825-1833